- Home
- EVRG vs ZBH Comparison
EVRG vs ZBH Comparison
Compare EVRG & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVRG | ZBH |
|---|---|---|
| Founded | 2017 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0B | 16.0B |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | EVRG | ZBH |
|---|---|---|
| Price | $86.24 | $95.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 21 |
| Target Price | $87.38 | ★ $101.00 |
| AVG Volume (30 Days) | 1.9M | ★ 2.0M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.42% | 1.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.64 | ★ 1.22 |
| Revenue | $5,961,600,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $6.52 | $4.96 |
| Revenue Next Year | $7.12 | $3.76 |
| P/E Ratio | $134.13 | ★ $75.47 |
| Revenue Growth | 1.95 | ★ 7.20 |
| 52 Week Low | $69.54 | $79.12 |
| 52 Week High | $88.62 | $108.29 |
Technical Indicators
Market Signals| Indicator | EVRG | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 52.86 | 62.84 |
| Support Level | $84.75 | $85.21 |
| Resistance Level | $88.37 | $96.45 |
| Average True Range (ATR) | 1.38 | 2.74 |
| MACD | -0.09 | 0.27 |
| Stochastic Oscillator | 47.54 | 85.27 |
Price Performance
Historical ComparisonAbout EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission. The utility has a combined rate base of more than $20 billion, about half in Kansas and the rest split between Missouri and interstate transmission. Evergy is one of the largest wind energy suppliers in the US.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.